Value of common stock issued as a result of the exercise of warrants.

No definition available.

Name:	aphb_CommonStockIssuedDuringPeriodValueWarrantsExercised
Namespace Prefix:	aphb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Fair value of derivative liability of warrants as of the balance sheet date.

+ References

No definition available.

+ Details

Name:	aphb_DerivativeWarrantsLiability
Namespace Prefix:	aphb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

This element represents that, the exercise price of stock issued during the period.

+ References

No definition available.

+ Details

Name:	aphb_StockIssuedDuringPeriodExercisePriceNewIssues2
Namespace Prefix:	aphb_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of new stock issued during the period.

+ References

No definition available.

+ Details

Name:	aphb_StockIssuedDuringPeriodSharesNewIssues2
Namespace Prefix:	aphb_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of warrants exercised during the period.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsExercisedDuringPeriodValue
Namespace Prefix:	aphb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

This element represents that, the warrants issuance costs for during the period.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsIssuanceCosts
Namespace Prefix:	aphb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

This element represents that, the exercise price of warrants issued during the period.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsIssuedDuringPeriodExercisePriceOfWarrants
Namespace Prefix:	aphb_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

This element represents that, the number of warrants issued during the period.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsIssuedDuringPeriodNumberOfWarrants
Namespace Prefix:	aphb_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of increase in the fair value of derivatives recognized in the income statement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a),(c),(d),(e)

-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959

+ Details

Name:	us-gaap_DerivativeGainOnDerivative
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of decrease in the fair value of derivatives recognized in the income statement.

+ References

+ Details

Name:	us-gaap_DerivativeLossOnDerivative
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 40

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6445032&loc=d3e90193-114008

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 480

-SubTopic 10

-Section S99

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

+ Details

Name:	us-gaap_ReclassificationsOfTemporaryToPermanentEquity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aphb_BiocontrolLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=aphb_WarrantsIssuedOnJune262014Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=aphb_SeriesBConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Warrants (Details Textual) (USD $)	12 Months Ended		1 Months Ended	12 Months Ended
Warrants (Details Textual) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Jun. 26, 2014	Dec. 31, 2011
Class of Warrant or Right [Line Items]
Derivative warrants liability	$ 172,000aphb_DerivativeWarrantsLiability	$ 16,311,000aphb_DerivativeWarrantsLiability
Derivative, Gain on Derivative	388,000us-gaap_DerivativeGainOnDerivative
Derivative, Loss on Derivative		14,214,000us-gaap_DerivativeLossOnDerivative
Warrants Issued on June 26, 2014 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercised During Period Value			3,855,714
Common Stock Issued During Period Value Warrants Exercised			2,734,151
Reclassifications of Temporary to Permanent Equity			1,595,000
Biocontrol Limited [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Number of Warrants				1,355,164
Warrants Issued During the Period, Exercise Price of Warrants				$ 0.46
Derivative warrants liability	5,654,000
Derivative, Gain on Derivative	9,066,000
Convertible Notes Payable [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Number of Warrants		7,030,387
Warrants Issued During the Period, Exercise Price of Warrants		$ 0.14
Series B Convertible Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Number of Warrants		12,499,996
Warrants Issued During the Period, Exercise Price of Warrants		$ 0.14
Common Stock [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues2		72,007,000
Stock Issued During Period, Exercise Price, New Issues2		$ 0.25
Private Placement [Member] \| Series B Convertible Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Number of Warrants		30,040,194
Warrants Issued During the Period, Exercise Price of Warrants		$ 0.14
Warrants Issuance Costs		$ 759,000
Private Placement [Member] \| Common Stock [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues2		4,320,420
Warrants Issued During the Period, Number of Warrants		4,320,420
Warrants Issued During the Period, Exercise Price of Warrants		$ 0.25